2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
| 热门AI工具： |
论文引言生成
New
AI 写作痕迹检测
Hot
学术改写降重
论文摘要生成
参考文献挖掘工具
审稿意见辅助撰写
|
查看更多AI工具 >> |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | PHARMACOLOGICAL RESEARCH PHARMACOL RES （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.1
90人评分
我要评分
声誉 8.5 影响力 7.4 速度 8.8 | |||||||||||||||||
| 期刊ISSN | 1043-6618 | 安装APP，查看期刊最新消息
| ||||||||||||||||
| E-ISSN | 1096-1186 | |||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||
| 实时影响因子 | 截止2026年9月20日：8.434 | |||||||||||||||||
| 2025-2026自引率 | 1.6%点击查看自引率趋势图 | |||||||||||||||||
| 五年IF （数据来源于网友提供） | 11.798数据由网友[storm_writer]收集提供 | |||||||||||||||||
| h-index | 118 | |||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||
| 期刊简介 |
| |||||||||||||||||
| 期刊官方网站 | https://www.journals.elsevier.com/pharmacological-research
投稿规范预检（避免 Desk Rejection） 开始检查>>
| |||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/YPHRS
AI辅助快速完成投稿信初稿 一键撰写投稿信>>
| |||||||||||||||||
| 该期刊中国学者近期发文 - New | Berberine alleviates postoperative cognitive dysfunction by suppressing microglial IDO1 induction and kynurenine pathway activation in aged mice Author: Yang, Jialin; Liu, Xiaohong; Zhang, Tongtong; Wei, Yuqian; Xie, Shenyuan; Pan, Weidong; Lin, Wenjun; Zheng, Xiaochun; Yao, Yusheng Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108405 Natural products for depression: Preclinical insights into microbiota-gut-brain axis modulation and pharmacological potential Author: Qiao, Xikai; Han, Donghe; Bai, Yuying; Wang, Rongxin; Xue, Xiaocong; Wang, Zhimei; Jin, Meihua; Tao, Ran Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108390 Systematic screening identifies USP20 as an accelerator of metabolic dysfunction-associated steatotic liver disease via driving de novo lipogenesis Author: Ma, Xiaoxuan; Qin, Weiwei; Feng, Zian; Luan, Nengneng; Pan, Ruru; Diao, Yanyan; Yin, Zequn; Xu, Suowen; Ge, Junbo; Zhang, Shuang; Duan, Yajun Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108406 Mitochondrial-centric regulatory networks in MASLD: Integrating quality control, organelle interactions, and gut-liver communication Author: Liu, Jingwen; Li, Kewei; Deng, Ying; Li, Xi; Yang, Ruhan; Huang, Ping; Li, Chunyan; Zhao, Yueshui; Du, Fukuan; Chen, Yu; Shen, Jing; Xiao, Zhangang; Zhu, Kangxing; Shui, Tao; Zhong, Jianqiao; Li, Mingxing; Wu, Xu Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108410 | |||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足PHARMACOLOGICAL RESEARCH的语言要求，还能让PHARMACOLOGICAL RESEARCH编辑和审稿人得到更好的审稿体验，让稿件最大限度地被PHARMACOLOGICAL RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（1篇） 论文致谢（7篇） 。
提交文稿 | |||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD4510; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：pharmacology、biomedical science、health science 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||
| 通讯方式 | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX | |||||||||||||||||
| 出版商 | Academic Press Inc. | |||||||||||||||||
| 涉及的研究方向 | 医学-药学 | |||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||
| 出版语言 | English | |||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||
| 出版年份 | 1989 | |||||||||||||||||
| 年文章数 | 421点击查看年文章数趋势图 | |||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.59% | |||||||||||||||||
| WOS期刊JCR分区 （ 2025-2026年最新版） | 注册或登录后，查看WOS分区等级 | |||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||
  | ||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1043-6618%5BISSN%5D | |||||||||||||||||
| 平均审稿速度 | 网友分享经验： 偏慢,4-8周 来源Elsevier官网： 平均5.5周 | |||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ USD4510; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在PHARMACOLOGICAL RESEARCH顺利发表。
快看看作者怎么说吧：服务好评（1篇） 论文致谢（7篇） 。 提交文稿 | |||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均6.7周 | |||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Berberine alleviates postoperative cognitive dysfunction by suppressing microglial IDO1 induction and kynurenine pathway activation in aged mice Author: Yang, Jialin; Liu, Xiaohong; Zhang, Tongtong; Wei, Yuqian; Xie, Shenyuan; Pan, Weidong; Lin, Wenjun; Zheng, Xiaochun; Yao, Yusheng Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108405 PubMed DOI |
| 2. | Natural products for depression: Preclinical insights into microbiota-gut-brain axis modulation and pharmacological potential Author: Qiao, Xikai; Han, Donghe; Bai, Yuying; Wang, Rongxin; Xue, Xiaocong; Wang, Zhimei; Jin, Meihua; Tao, Ran Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108390 PubMed DOI |
| 3. | Systematic screening identifies USP20 as an accelerator of metabolic dysfunction-associated steatotic liver disease via driving de novo lipogenesis Author: Ma, Xiaoxuan; Qin, Weiwei; Feng, Zian; Luan, Nengneng; Pan, Ruru; Diao, Yanyan; Yin, Zequn; Xu, Suowen; Ge, Junbo; Zhang, Shuang; Duan, Yajun Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108406 PubMed DOI |
| 4. | Mitochondrial-centric regulatory networks in MASLD: Integrating quality control, organelle interactions, and gut-liver communication Author: Liu, Jingwen; Li, Kewei; Deng, Ying; Li, Xi; Yang, Ruhan; Huang, Ping; Li, Chunyan; Zhao, Yueshui; Du, Fukuan; Chen, Yu; Shen, Jing; Xiao, Zhangang; Zhu, Kangxing; Shui, Tao; Zhong, Jianqiao; Li, Mingxing; Wu, Xu Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108410 DOI |
| 5. | Schisandrin B protects against oxaliplatin-induced liver injury by suppressing ferroptosis via the canonical KEAP1-Nrf2 and non-canonical microbiota-driven Lactobacillus reuteri-CLA-Nrf2 axes Author: Huang, Ping; Li, Shan; Liu, Yichen; Li, Jinying; Liu, Bingchen; Li, Na; Wang, Cheng; Xia, Chunhua; Liu, Fanglan Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108408 PubMed DOI |
| 6. | Harnessing autophagy-dependent ferroptosis: Mechanisms and therapeutic opportunities in human diseases Author: Cui, Xiao; Dong, Xinzhu; Li, Yang; Yuan, Ziyue; Wang, Lei; Zhang, Lan; Ma, Yi Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 232, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108401 PubMed DOI |
| 7. | Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications Author: Yang, Qianyu; Shi, Runlin; Zhang, Chenyang; Sun, Wei; Chen, Guangjin Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 231, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108346 PubMed DOI |
| 8. | From multi-target to network synergy: A systematic review of how traditional Chinese medicine acts against myocardial ischemia-reperfusion injury via miRNA-mediated systemic communication Author: Xu, De-Sheng; He, Jiang-Xuan; Yan, Jia-Hui; Lin, Shi-Min; Fan, Zheng; Mo, Wen-Jie; Liao, Meng-Qi; Xie, Ying; Li, Yuan-Yuan; Zhou, Hua Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 231, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108362 PubMed DOI |
| 9. | The JAK1 inhibitor golidocitinib boosts therapeutic potency of DLL3-targeted CAR-T therapy for small cell lung cancer Author: Li, Mengwei; Zhang, Yao; Li, Fangqi; Xia, Yuchen; Wang, Wanting; Li, Jingwen; Du, Huawei; Tan, Ruiting; Qiang, Huiping; Wang, Yue; Cao, Shuhui; Huang, Litang; Wu, Erpeng; Yang, Yu; Zhang, Bo; Yang, Xuanming; Zhou, Yan; Zhang, Chi; Zhong, Hua Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 231, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108347 PubMed DOI |
| 10. | A multi-component intervention enhances intestinal urate excretion and improves metabolic and immune homeostasis in diet-induced hyperuricemia Author: Fan, Mingyuan; Yuan, Jiushu; Xie, Hongyan; Li, Qian; Lu, Dingyi; Zhang, Sai; Wang, Qiangyan; Wang, Gang; Xie, Chunguang; Gao, Hong Journal: PHARMACOLOGICAL RESEARCH. 2026; Vol. 231, Issue , pp. -. DOI: 10.1016/j.phrs.2026.108361 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共610条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
